<DOC>
	<DOCNO>NCT00004807</DOCNO>
	<brief_summary>OBJECTIVES : I . Extend current knowledge phenotype natural history Rett syndrome ( RS ) . II . Continue search cytogenetic and/or DNA marker . III . Study effect cholinergic drug base preliminary evidence reduce level brain acetylcholine , continue supportive care modify seizure , respiratory abnormality , motor disturbance , improve nutrition , behavior , learn . IV . Identify target future therapeutic intervention , e.g. , growth factor , influence neurologic recovery .</brief_summary>
	<brief_title>Study Pathogenesis Rett Syndrome</brief_title>
	<detailed_description>PROTOCOL OUTLINE : Patients receive comprehensive clinical evaluation include ophthalmologic exam ; speech , communication , developmental assessment ; nutritional evaluation ; neurologic exam ; respiratory monitoring ; cytogenetic study . Selected patient malnutrition give night feeding Pediasure Fiber nasogastric tube . Specific recommendation feed technique diet make . Selected patient seizure severe hyperventilation progressive rigidity nonrandomly assign dextromethorphan topiramate therapy . Oral dextromethorphan maintain 6 month 1 year ; duration therapy depend response . Oral topiramate give 6 month 1 year , Aricept 6 month 1 year . Concurrent anticonvulsant may require dose adjustment protocol . Supportive care constipation , scoliosis , weight loss allow .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Rett Syndrome</mesh_term>
	<mesh_term>Dextromethorphan</mesh_term>
	<mesh_term>Donepezil</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Rett syndrome Diagnosis confirm study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 1998</verification_date>
	<keyword>Rett syndrome</keyword>
	<keyword>neurologic psychiatric disorder</keyword>
	<keyword>rare disease</keyword>
</DOC>